ReviewClinical nephrology2015
Peritoneal dialysis: update on patient survival.
Review in Clinical nephrology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 27 citations in OpenAlex.
- Outcomes of Dialysis Modality Switch: A Matched Cohort Analysis from a National Renal Replacement Therapy Registry, 2010-2022.Journal of clinical medicine · 2026Article
- Outcomes of diabetic patients undergoing peritoneal dialysis in the French Language Peritoneal Dialysis Registry.Clinical kidney journal · 2026Article
- Immediate-start peritoneal dialysis without break-in-period: an 18-year retrospective cohort study on patient survival.Kidney research and clinical practice · 2025Article
- Article
- Deletion of p38 MAPK in macrophages ameliorates peritoneal fibrosis and inflammation in peritoneal dialysis.Scientific reports · 2024Article
- Cardiovascular and All-Cause Mortality Is Affected by Serum Magnesium and Diet Pattern in a Cohort of Dialysis Patients.Journal of clinical medicine · 2024Article
- Article
- Scope and heterogeneity of outcomes reported in randomized trials in patients receiving peritoneal dialysis.Clinical kidney journal · 2021Article
- Long-term clinical outcomes of peritoneal dialysis patients: 9-year experience of a single centre in TurkeyTurkish journal of medical sciences · 2020Article
- Association of incident dialysis modality with mortality: a protocol for systematic review and meta-analysis of randomized controlled trials and cohort studies.Systematic reviews · 2019Article
- Propensity Score-Matched Analysis of the Survival Benefit from Kidney Transplantation in Patients with End-Stage Renal Disease.Journal of clinical medicine · 2018Article
- Regimen-related Mortality Risk in Patients Undergoing Peritoneal Dialysis Using Hypertonic Glucose Solution: A Retrospective Cohort Study.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2018Article
- Survival and time-to-transplantation of peritoneal dialysis versus hemodialysis for end-stage renal disease patients: competing-risks regression model in a single Italian center experience.Journal of nephrology · 2017Observational
- Human Peritoneal Mesothelial Cell Death Induced by High-Glucose Hypertonic Solution Involves CaFrontiers in physiology · 2017Article
- Patient characteristics and risk factors of early and late death in incident peritoneal dialysis patients.Scientific reports · 2016Article
- The Course of Quality of Life in Patients on Peritoneal Dialysis: A 12-month Prospective Observational Cohort Study.International journal of behavioral medicine · 2016Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Due to ongoing limitations in the availability and timeliness of kidney transplantation, most patients with end-stage renal disease (ESRD) require some form of dialysis during their lifetime. Worldwide, ESRD patients most commonly receive hemodialysis (HD) or one of two forms of peritoneal dialysis (PD), continuous ambulatory PD (CAPD) or automated PD (APD). In this review, we analyze the data available from the last several decades on overall survival associated with HD as compared to PD as well as with CAPD compared to APD. Because of the inherent difficulty in randomly assigning patients to different dialysis modalities, the survival data available are virtually all observational and fraught with many confounding factors and limitations. However, over the last 10 - 15 years as overall survival of dialysis patients has steadily improved and statistical methods to analyze observational data have evolved, a pattern of virtual equivalence in survival among patients on HD vs. PD and on CAPD vs. APD has emerged. As such, impact upon lifestyle and upon quality of life likely should remain the predominant factors in guiding nephrologists and their patients in their choice of dialysis modality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.